Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Liv Johannessen

Antitumor Synergy With SY-1425, a Selective RARα Agonist, and Hypomethylating Agents in Retinoic Acid Receptor Pathway Activated Models of Acute Myeloid Leukemia

Haematologica

Hematology

2018

English

Development of Selective Covalent Janus Kinase 3 Inhibitors

Journal of Medicinal Chemistry

Drug Discovery

Molecular Medicine

2015

English

Related publications

Combination Therapies of Hypomethylating Agents for Elderly Patients With Acute Myeloid Leukemia

Acta Haematologica Polonica

Oncology

Hematology

2018

English

Acute Myeloid Leukemia After Myelodysplastic Syndrome and Failure of Therapy With Hypomethylating Agents: An Emerging Entity With a Poor Prognosis

Clinical Lymphoma, Myeloma and Leukemia

English

Reprogramming Acute Myeloid Leukemia Into Sensitivity for Retinoic-Acid-Driven Differentiation

Experimental Hematology

English

Novel Agents in Acute Myeloid Leukemia

International Journal of Hematology

Hematology

2012

English

TRIM24 Mediates the Interaction of the Retinoic Acid Receptor Alpha (RARα) With the Proteasome

English

Author Correction: Lineage Tracing of Acute Myeloid Leukemia Reveals the Impact of Hypomethylating Agents on Chemoresistance Selection

Nature Communications

English

Myeloid Lineage Enhancers Drive Oncogene Synergy in CEBPA/CSF3R Mutant Acute Myeloid Leukemia

Nature Communications

English

Enhancement of the Inducible NO Synthase Activation by Retinoic Acid Is Mimicked by RARα Agonist in Vivo

American Journal of Physiology - Endocrinology and Metabolism

English

4-Oxo Retinoic Acid for Refractory Acute Promyelocytic Leukemia in Children With All-Trans Retinoic Acid Therapy.

Journal of Nutritional Science and Vitaminology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Liv Johannessen

Antitumor Synergy With SY-1425, a Selective RARα Agonist, and Hypomethylating Agents in Retinoic Acid Receptor Pathway Activated Models of Acute Myeloid Leukemia

Development of Selective Covalent Janus Kinase 3 Inhibitors

Related publications

Combination Therapies of Hypomethylating Agents for Elderly Patients With Acute Myeloid Leukemia

Acute Myeloid Leukemia After Myelodysplastic Syndrome and Failure of Therapy With Hypomethylating Agents: An Emerging Entity With a Poor Prognosis

Reprogramming Acute Myeloid Leukemia Into Sensitivity for Retinoic-Acid-Driven Differentiation

Novel Agents in Acute Myeloid Leukemia

TRIM24 Mediates the Interaction of the Retinoic Acid Receptor Alpha (RARα) With the Proteasome

Author Correction: Lineage Tracing of Acute Myeloid Leukemia Reveals the Impact of Hypomethylating Agents on Chemoresistance Selection

Myeloid Lineage Enhancers Drive Oncogene Synergy in CEBPA/CSF3R Mutant Acute Myeloid Leukemia

Enhancement of the Inducible NO Synthase Activation by Retinoic Acid Is Mimicked by RARα Agonist in Vivo

4-Oxo Retinoic Acid for Refractory Acute Promyelocytic Leukemia in Children With All-Trans Retinoic Acid Therapy.